Stock & Company Details
Design Therapeutics Inc $DSGN
Price:
46,691,331
62M
$904M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
DSGN technical indicators
Latest Design Therapeutics Inc (DSGN) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
68.94 1.9%
MACD:
0.63 17.4%
SMA 50:
$12.51 0.2%
SMA 200:
$9.87 0.4%
EMA 20:
$12.60 1.6%
Bollinger Bands:
14.91 / 8.90
Stochastic:
81.99 4.0%
ADX 14:
23.65 6.7%
ATR 14:
0.92 4.3%
CCI 20:
127.90 5.9%
OBV:
-2.83M 29.8%
ROC 12:
37.42% 11.4%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.
Finance Bot
Ask your questions
Start by typing a question below.
